Share Email Print
cover

Proceedings Paper • new

Measurement of skin autofluorescence by fluorescent spectrometry for diabetes diagnostics and control
Author(s): Yulia A. Kononova; Anastasiya G. Arkhipova; Garry V. Papayan; Mikhail K. Khodzitsky; Alina Yu. Babenko; Elena N. Grineva
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Introduction. Fluorescence spectrometry allows studying skin autofluorescence (AF), which shows content of advanced glycation end products. The aim of study was to determine possibility of using the experimental sample of fiber optic spectrometer FOS-1 for diabetes mellitus diagnostics and control, including noninvasive diagnostics of complications.

Methods. We involved 36 healthy participants, 13 type 1 diabetic patients, 10 type 2 diabetic patients. The 1st and the 2nd groups were comparable by the age, gender, skin reflection coefficient, characterizing skin phototype and degree of tanning. Skin AF was measured at a wavelength of 460 nm with excitation of 365 nm. To reduce effect of skin pigmentation, ratio of fluorescent signal to signal of reflection in excitation region was used as measured parameter.

Results. Significant correlation between AF intensity and age was found in type 1 diabetic and control groups (R=0.6, р<0.05 and R=0.43, p<0.05, respectively). No significant difference in AF level was found between these groups: median AF was 0.87 (0.86; 0.89) arb. units and 0.85 (0.77; 0.88) arb. units respectively. In type 1 diabetic group AF also positively correlated, although not statistically significantly, with diabetes duration, glycosylated hemoglobin level, average daily glucose level (R=0.52, p=0.06; R=0.45, p=0.09 and R=0.56, p=0.07 respectively). The median AF was 14.7% higher (p=0.34) in patients with several diabetes complications than in diabetics with 1 complication and 13.9% (р=0.19) higher than in patients without complications.

Conclusion. Obtained data show possibility of using the described method with spectrometer FOS-1 for diabetes control and for diagnostics of microvascular complications.

Paper Details

Date Published: 17 May 2018
PDF: 8 pages
Proc. SPIE 10685, Biophotonics: Photonic Solutions for Better Health Care VI, 106852N (17 May 2018); doi: 10.1117/12.2307250
Show Author Affiliations
Yulia A. Kononova, Almazov National Medical Research Ctr. (Russian Federation)
Saint Petersburg National Research Univ. of Information Technologies, Mechanics and Optics (Russian Federation)
Anastasiya G. Arkhipova, Almazov National Medical Research Ctr. (Russian Federation)
Garry V. Papayan, Almazov National Medical Research Ctr. (Russian Federation)
Saint Petersburg National Resarch Univ. of Information Technologies, Mechanics and Optics (Russian Federation)
Pavlov First Saint Petersburg State Medical Univ. (Russian Federation)
Mikhail K. Khodzitsky, Saint Petersburg National Research Univ. of Information Technologies, Mechanics and Optics (Russian Federation)
Alina Yu. Babenko, Almazov National Medical Research Ctr. (Russian Federation)
Saint Petersburg National Research Univ. of Information Technologies, Mechanics and Optics (Russian Federation)
Elena N. Grineva, Almazov National Medical Research Ctr. (Russian Federation)
Saint Petersburg National Research Univ. of Information Technologies, Mechanics and Optics (Russian Federation)


Published in SPIE Proceedings Vol. 10685:
Biophotonics: Photonic Solutions for Better Health Care VI
Jürgen Popp; Valery V. Tuchin; Francesco Saverio Pavone, Editor(s)

© SPIE. Terms of Use
Back to Top